The prevalence of chemosensory dysfunction in patients with COVID-19 varies greatly
between populations. It is unclear whether such differences are due to factors at the level of …

Background: There is growing evidence of otoneurological involvement of SARS-CoV-2,
such as tinnitus and balance disorders and smell and taste disorders, but HL in COVID-19 …

Injudicious consumption of antibiotics in the past few decades has arisen the problem of
resistance in pathogenic organisms against most antibiotics and antimicrobial agents …

Since the outbreak of the SARS-CoV-2 pandemic, olfactory disorders have been reported as
a frequent symptom of COVID-19; however, its pathogenesis is still debated. The aim of this …

Abstract Background Among Coronavirus Disease 2019 (COVID-19) manifestations,
Olfactory (OD) and Gustatory (GD) Dysfunctions (OGD) have drawn considerable attention …

Background: Various symptoms have been associated with COVID-19, but little is known
about the impacts of COVID-19 on the sensory system, risk factors, and the duration of …

Commercially available smell tests are primarily used in research or in-depth clinical
evaluations and are too costly and time-consuming for population surveillance in health …

Anosmia, a neuropathogenic condition of loss of smell, has been recognized as a key
pathogenic hallmark of the current pandemic SARS-CoV-2 infection responsible for COVID …

The coronavirus disease 2019 (COVID-19) pandemic is wreaking havoc on public-health
and economic systems worldwide. Among the several neurological symptoms of patients …

Approximately 5% of the general population is affected by functional anosmia with
approximately additional 15% exhibiting decreased olfactory function. Many of these …